Twist Bioscience Corporation
NASDAQ:TWST
Overview | Financials
 | Company Name | Twist Bioscience Corporation | 
| Symbol | TWST | 
| Currency | USD | 
| Price | 26.25 | 
| Market Cap    |  1,584,473,625 | 
| Dividend Yield    |  0% | 
| 52-week-range | 24.28 - 55.33 | 
| Industry | Diagnostics & Research | 
| Sector | Healthcare | 
| CEO | Dr. Emily Marine Leproust Ph.D. | 
| Website | https://www.twistbioscience.com | 
An error occurred while fetching data.
About Twist Bioscience Corporation
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, 
 Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD







